Details for New Drug Application (NDA): 070541
✉ Email this page to a colleague
NDA 070541 describes EPITOL, which is a drug marketed by Teva and is included in two NDAs. It is available from one supplier. Additional details are available on the EPITOL profile page.
The generic ingredient in EPITOL is carbamazepine. There is one drug master file entry for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the carbamazepine profile page.
The generic ingredient in EPITOL is carbamazepine. There is one drug master file entry for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the carbamazepine profile page.
Summary for 070541
| Tradename: | EPITOL |
| Applicant: | Teva |
| Ingredient: | carbamazepine |
| Patents: | 0 |
Suppliers and Packaging for NDA: 070541
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| EPITOL | carbamazepine | TABLET;ORAL | 070541 | ANDA | Bryant Ranch Prepack | 63629-8753 | 63629-8753-1 | 1000 TABLET in 1 BOTTLE (63629-8753-1) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 200MG | ||||
| Approval Date: | Sep 17, 1986 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
